Immunovant, Inc. Stock News

Credit Suisse downgraded Immunovant Inc (NASDAQ:IMVT) to Underperform from Neutral and lowered the price target to $7 from $12.  Analyst Tiago Fauth says that the downgrade reflects ongoing cl

Immunovant Inc (NASDAQ: IMVT) has received a $200 million strategic investment from Roivant Sciences that the Company will use to advance IMVT-1401 in multiple indications. Roivant has purchased

NEW YORK, Aug. 02, 2021 (GLOBE NEWSWIRE) -- Immunovant, Inc. (Nasdaq: IMVT), a clinical-stage biopharmaceutical company focused on enabling normal lives for people with autoimmune diseases, today anno

Biotech stocks are tricky investment bets that require careful analysis and scrutiny. A stock that has fallen off a cliff in reaction to a binary event can neither be written off entirely nor picked a

Immunovant, Inc. (IMVT) reported earnings 30 days ago. What's next for the stock?

Immunovant's (IMVT) earnings beat estimates in fourth-quarter fiscal 2021. Focus remains on lead pipeline candidate IMVT-1401.

The stock price of Immunovant Inc (NASDAQ: IMVT) fell by over 20% pre-market. This is why it happened.

NEW YORK, June 01, 2021 (GLOBE NEWSWIRE) -- Immunovant, Inc. (Nasdaq: IMVT), a clinical-stage biopharmaceutical company focused on enabling normal lives for people with autoimmune diseases, today prov

LOS ANGELES, April 20, 2021 /PRNewswire/ --  The Schall Law Firm , a national shareholder rights litigation firm, reminds investors of a class action lawsuit against Immunovant, Inc. ("Immunovant" o

NEW YORK, April 19, 2021 /PRNewswire/ -- Bernstein Liebhard, a nationally acclaimed investor rights law firm, reminds investors of the deadline to file a lead plaintiff motion in a securities class ac

Los Angeles, California--(Newsfile Corp. - April 19, 2021) - The Schall Law Firm, a national shareholder rights litigation firm, reminds investors of a class action lawsuit against Immunovant, Inc. ("

New York, New York--(Newsfile Corp. - April 18, 2021) - Bronstein, Gewirtz & Grossman, LLC notifies investors that a class action lawsuit has been filed against Immunovant, Inc. ("Immunovant" or "the

New York, New York--(Newsfile Corp. - April 16, 2021) - Bernstein Liebhard, a nationally acclaimed investor rights law firm, reminds investors of the deadline to file a lead plaintiff motion in a secu

New York, New York--(Newsfile Corp. - April 16, 2021) - The following statement is being issued by Levi & Korsinsky, LLP:To: All persons or entities who purchased or otherwise acquired securities of I

Atlanta, Georgia--(Newsfile Corp. - April 16, 2021) - Holzer & Holzer, LLC reminds investors who suffered financial losses on purchases of Immunovant, Inc. ("Immunovant" or the "Company") (NASDAQ: IMV